Please login to the form below

Not currently logged in


This page shows the latest Aptiv news and features for those working in and with pharma, biotech and healthcare.

Icon boost medical device trial capability with Aptiv acquisition

Dublin-based contract research organisation Icon has acquired Aptiv Solutions for $143.5m, boosts its capabilities to run adapative and medical device trials.  . ... Aptiv Solutions' adaptive trial capabilities will further differentiate and enhance our

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Furiex/ Forest Laboratories, Andromeda Biotech/ Hyperion Therapeutics), OTC (Insight Pharmaceuticals/ Prestige Brands), Diagnostics (Iquum/ Roche), CRO (Aptiv Solutions/ ICON) and even Stem Cells (California Stem Cell/ NeoStem).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....